Silexion Therapeutics Corp (SLXN)
Nasdaq: SLXN · Biological Products, (No Diagnostic Substances) · Ramat Gan, IL · filing with the SEC since 2024
Who owns Silexion Therapeutics Corp
As filed with the SECHolders of 5% or more
2
Moringa Sponsor, LP holds 17.7% of Ordinary Shares, par value $0.0135 per share, as its SCHEDULE 13D/A filed Sep 28, 2026 says.
Directors and officers
9
report now, of 10 people on the record since 2024. Their holdings as a group are not read here.
Institutions as a whole
n/a
The record does not read the share held by managers that file Form 13F, so none is printed and no split of the rest is estimated. What it holds is the 2 named at left.
Holders of 5% or moreshare of the class, as filed
Moringa Sponsor, LP
SCHEDULE 13D/A · filed Sep 28, 2026 · Ordinary Shares, par value $0.0135 per share · 25% in Aug 19, 2026
Lincoln Alternative Strategies LLC
SCHEDULE 13G · filed Sep 15, 2025 · Ordinary Shares, par value $0.0009 per share
Mitchell P. Kopin
SCHEDULE 13G · filed Aug 18, 2026 · Ordinary shares, par value $0.135 per share · reported falling below 5%, from 0% in Aug 13, 2026
Lind Global Fund III LP
SCHEDULE 13G/A · filed May 15, 2026 · Ordinary shares, par value $0.0135 per share · reported falling below 5%, from 6.4% in Nov 14, 2025
Orca Capital AG
SCHEDULE 13G/A · filed Sep 15, 2025 · Ordinary Shares, par value $0.0135 per share · reported falling below 5%, from 6.2% in Sep 15, 2025
CVI Investments, Inc.
SCHEDULE 13G/A · filed May 12, 2025 · Ordinary Shares, par value $0.0009 per share · reported falling below 5%, from 8.5% in Jan 23, 2025
Goldman Sachs Group Inc.
SCHEDULE 13G/A · filed May 13, 2025 · Ordinary Shares, par value $0.0001 per share · reported falling below 5%, from 6.6% in Feb 10, 2025
Wildcat Capital Management, LLC
SCHEDULE 13D/A · filed Jun 26, 2025 · Ordinary Shares, par value $0.0009 per share · reported falling below 5%
What SLXN reports owning in othersstakes of 5% or more, and other ties
4 subsidiaries in 4 countries, from the list filed with the 10-K filed Mar 17, 2026.
Insider tradesForm 4
1sales
0purchases
0sales on a scheduled plan
1people selling
$0sold, in dollars
$0bought, in dollars
Open-market trades on Form 4 from Sep 30, 2025 to Sep 30, 2026. A scheduled plan is a selling program set in advance under SEC rule 10b5-1. The trades are listed as filed and do not feed the grade.
By calendar yearSoldBought
No open-market trade is on the record for these years.
2026 runs to Sep 30, 2026. Dollars as filed, summed by the transaction date.
People who traded in the window1 of 14 on the roster
| Person | Role as filed | Sales | Sold | On a plan | Buys | Bought |
|---|---|---|---|---|---|---|
| Shirvan Mitchell | CSO and CDO | 1 | $0 | 0 | 0 | $0 |